1
Return

Clinical Symptoms Do Not Distinguish Sucrose Malabsorption From SIBO

delete2026-03-31
delete0
PRE
AI
R
Ramprasad, Chethan *
V
Vikram Rangan
C
Colin O. Wu
M
Makwana, Katha
S
Samantha Proctor
S
Sarah Ballou
J
Johanna Iturrino
S
Singh, Prashant
A
Anthony Lembo
T
Trisha S. Pasricha
H
Halbert, Louise
M
McCarthy, Ashley
J
Judy Nee
DOI:10.1111/nmo.70304delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
Background Sucrose malabsorption and small intestinal bacterial overgrowth (SIBO) present with symptoms that overlap with those of disorders of gut-brain interaction (DGBI). Recent studies suggest that sucrose malabsorption is more prevalent than previously thought. This study aims to determine the prevalence of sucrose malabsorption based on 13C-sucrose breath test (SBT) in patients undergoing SIBO breath testing and assess whether symptoms distinguish sucrose malabsorption from SIBO.Methods Three hundred patients referred for SIBO breath testing between August 2020 and March 2022 were recruited and asked to complete the Rome IV Questionnaire for bowel disorders, Irritable Bowel Syndrome Severity Score (IBS-SSS), and the Patient Assessment of Gastrointestinal Disorders Symptom Severity Index (PAGI-SYM). After in person SIBO breath testing, they were provided an at-home 13C-SBT.Results One-hundred-and-forty patients returned the SBT. Of the SIBO negative patients, 22% (25/113) were SBT positive. No statistically significant differences were found in predominant symptoms or Rome IV diagnoses (IBS, functional constipation, or functional diarrhea), bloating frequency, IBS-SSS, or PAGI-SYM Scores between SBT positive and SBT negative patients. SBT positive only patients (n = 24) reported less abdominal pain (p = 0.04) than abnormal SIBO test only patients (n = 23).Conclusion Sucrose malabsorption was present in 22% of SIBO negative patients, indicating that it is a possible contributor to DGBI symptoms. Symptom profile alone did not predict sucrose malabsorption, nor distinguish between sucrose malabsorption and SIBO. This emphasizes the importance of considering carbohydrate malabsorption syndromes, such as sucrose malabsorption, when evaluating patients with symptoms consistent with functional gastrointestinal disorders (FGID).
Keywords:
carbohydrate malabsorption
functional gastrointestinal disorders
gastrointestinal symptoms
hydrogen breath test
small intestinal bacterial overgrowth

Journal

N
Neurogastroenterology and Motility
IF:
2.9
Papers:
5.9K
Citations:
1.0W

Organization

B
beth israel deaconess medical center
Scholars:
739
Papers: 384
Citations: 0
H
Harvard University
Scholars:
26.2W
Papers: 21.9W
Citations: 28.7W
H
harvard university medical affiliates
Scholars:
5.7W
Papers: 4.5W
Citations: 36
Cited Papers

Cited Papers

Citing Papers

Citing Papers